Document is current
Any future updates will be listed below
-
Authors
Forsgren, Mikael F.
Pine, Stewart
Harrington, Claire Royalle
Gregory, Dyanna
Petersson, Mikael
Rinella, Mary
Leinhard, Olof Dahlqvist
VanWagner, Lisa B.
-
Funding
Funding for this research was provided by:
National Institutes of Health (UL1TR001422)
National Heart, Lung, and Blood Institute (K23HL136891)
- License Information
-
More Information
Article History
Received: 22 December 2023
Accepted: 19 September 2024
First Online: 9 October 2024
Declarations
:
: The studies involving humans were approved by Northwestern University Institutional Review Board, USA. Additional data used in this study was acquired from the UK Biobank resource, project ID 6569. The UK Biobank was approved by the North West Multicenter Research Ethics Committee, UK. The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study.
: N/A.
: MFF is an employee and shareholder of AMRA Medical AB. MP is an employee and shareholder of AMRA Medical AB. ODL is an employee, shareholder, and board member of AMRA Medical AB. Dr. VanWagner serves as an advisor for Gerson Lehrman Group, AlphaSights, and Noble Insights, receives research support from W.L. Gore & Associates and provides expert witness services outside the submitted work.
